ST. Francis Hospital INC.

ST. Francis Hospital INC. was paid $43.28M by Medicaid between Jan 2018 and Dec 2024, across 266 billing codes. Its largest line is 99284, emergency room visit (serious) — 19% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	253,594	$776K
2019	249,681	$4.90M
2020	155,372	$11.32M
2021	71,757	$7.27M
2022	67,473	$7.21M
2023	72,582	$7.10M
2024incomplete	45,128	$4.69M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	19%	31,845	27,534	$8.03M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	16%	39,260	35,021	$7.13M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.4%	11,003	9,166	$2.77M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	5.5%	87,204	29,629	$2.40M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.9%	12,366	11,300	$1.69M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.3%	3,108	2,686	$1.43M
80053	Comprehensive metabolic panel	3.2%	19,873	16,437	$1.36M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.3%	35,092	28,183	$992K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.1%	18,476	15,471	$925K
84703		2.0%	17,704	15,464	$868K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	2.0%	8,086	7,235	$865K
80048	Basic metabolic panel (calcium, ionized)	1.9%	23,936	18,127	$815K

254 more codes

93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.9%	15,666	$813K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.7%	15,404	$744K
76801		1.5%	2,531	$663K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.1%	2,066	$463K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.1%	2,056	$462K
70450	Computed tomography, head or brain; without contrast material	1.0%	4,065	$448K
G0378	Hospital observation service, per hour	1.0%	2,913	$437K
36415	Collection of venous blood by venipuncture	1.0%	39,707	$434K
81001		<1%	20,233	$383K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,197	$370K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	7,593	$354K
80061	Lipid panel	<1%	6,356	$321K
76830	Ultrasound, transvaginal	<1%	1,764	$307K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	7,596	$273K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	2,134	$223K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	686	$198K
96375	Therapeutic injection; each additional sequential IV push	<1%	10,717	$192K
96361	Intravenous infusion, hydration; each additional hour	<1%	8,922	$186K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,094	$181K
71046	Radiologic examination, chest; 2 views	<1%	4,991	$172K
71275	Computed tomographic angiography, chest, with contrast material	<1%	544	$164K
84443	Thyroid stimulating hormone (TSH)	<1%	5,272	$164K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	8,620	$164K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	788	$159K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,077	$159K
84484		<1%	12,073	$158K
87086	Culture, bacterial; quantitative colony count, urine	<1%	7,202	$157K
80365		<1%	4,427	$151K
80348		<1%	4,249	$150K
80076		<1%	3,761	$145K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,430	$142K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,868	$134K
71045	Radiologic examination, chest; single view	<1%	7,116	$133K
93976		<1%	1,780	$129K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	3,149	$118K
84702		<1%	2,275	$116K
83690		<1%	8,280	$116K
80050	General health panel	<1%	956	$115K
83735		<1%	8,607	$110K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	2,745	$98K
85027		<1%	12,118	$98K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,561	$97K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,416	$96K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,843	$93K
73630		<1%	2,050	$90K
J7030	Infusion, normal saline solution , 1000 cc	<1%	15,868	$88K
86803		<1%	1,567	$88K
83605		<1%	4,491	$81K
73610		<1%	1,588	$80K
93971		<1%	967	$78K
73562		<1%	1,575	$77K
86592		<1%	3,889	$76K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	3,323	$73K
87340		<1%	2,826	$68K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	881	$66K
73030		<1%	1,515	$65K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	4,309	$65K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	140	$62K
85610		<1%	10,692	$61K
73130		<1%	1,485	$58K
85730		<1%	8,465	$56K
87040		<1%	2,919	$56K
80320		<1%	2,436	$55K
81003		<1%	7,092	$54K
97803		<1%	1,007	$51K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	588	$51K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,439	$49K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,095	$46K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,100	$45K
86900		<1%	4,105	$43K
70486		<1%	539	$42K
85379		<1%	2,524	$41K
80074		<1%	441	$41K
85007		<1%	5,613	$38K
82043		<1%	778	$38K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	2,772	$37K
87186		<1%	1,896	$37K
86901		<1%	4,105	$36K
84439		<1%	1,105	$34K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,661	$33K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	3,773	$33K
82728		<1%	1,246	$33K
83880		<1%	1,744	$33K
73560		<1%	1,351	$32K
73565		<1%	1,216	$32K
73110		<1%	839	$32K
76642		<1%	185	$31K
93970		<1%	289	$28K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	229	$28K
86850		<1%	3,644	$28K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	2,483	$26K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	995	$26K
82950		<1%	1,063	$26K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	94	$25K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	183	$24K
10060		<1%	542	$24K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	17,081	$24K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,623	$22K
A0425	Ground mileage, per statute mile	<1%	89,123	$22K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	3,889	$21K
72110		<1%	548	$20K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	172	$20K
82550		<1%	3,388	$19K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,375	$19K
71250		<1%	241	$19K
87081		<1%	1,211	$18K
99213	Doctor's office visit, returning patient (routine)	<1%	652	$18K
94644		<1%	759	$17K
87070		<1%	1,010	$16K
84460		<1%	649	$15K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	122	$15K
96376		<1%	1,285	$15K
83540		<1%	1,113	$14K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	344	$14K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	183	$13K
73502		<1%	806	$12K
97597		<1%	326	$12K
84450		<1%	461	$11K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	732	$11K
87077		<1%	138	$11K
87481		<1%	430	$11K
84466		<1%	1,023	$10K
87512		<1%	430	$10K
86762		<1%	1,488	$9K
82248		<1%	255	$9K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	9,507	$9K
80069		<1%	427	$9K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,874	$9K
90714		<1%	1,014	$8K
80081		<1%	490	$8K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,005	$8K
82607		<1%	602	$8K
82947		<1%	329	$8K
72131		<1%	13	$7K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	903	$7K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	524	$7K
93017		<1%	102	$7K
82553		<1%	1,456	$7K
88342		<1%	424	$6K
87147		<1%	637	$6K
82570		<1%	677	$6K
97010		<1%	2,465	$6K
86141		<1%	709	$6K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	4,139	$5K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,516	$5K
97162		<1%	275	$5K
J7050	Infusion, normal saline solution, 250 cc	<1%	2,287	$5K
J2704	Injection, propofol, 10 mg	<1%	4,564	$5K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,386	$5K
87205		<1%	1,085	$4K
72100		<1%	261	$4K
85651		<1%	912	$4K
A0380	Bls mileage (per mile)	<1%	1,610	$4K
93975		<1%	81	$4K
73080		<1%	119	$4K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	424	$3K
62323		<1%	16	$3K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,563	$3K
12001		<1%	124	$3K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	13	$3K
87522	Neg quan hep c or qual rna	<1%	37	$3K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	186	$3K
J2060	Injection, lorazepam, 2 mg	<1%	1,196	$2K
84480		<1%	71	$2K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	30	$2K
83655		<1%	169	$2K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,786	$2K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,400	$2K
97802		<1%	29	$2K
94760		<1%	1,406	$2K
99214	Doctor's office visit, returning patient (more involved)	<1%	68	$2K
80362		<1%	17	$2K
76536		<1%	44	$2K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,155	$2K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	912	$2K
96367		<1%	492	$2K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	308	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	682	$1K
83021		<1%	409	$1K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,642	$1K
83615		<1%	101	$991.95
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	220	$952.28
83020		<1%	18	$897.59
J1815	Injection, insulin, per 5 units	<1%	850	$874.55
J1630	Injection, haloperidol, up to 5 mg	<1%	781	$865.37
84100		<1%	274	$861.58
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	71	$843.80
97161		<1%	74	$828.60
86038		<1%	42	$818.36
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	42	$779.49
76819	Fetal biophysical profile; without non-stress testing	<1%	396	$728.85
82746		<1%	110	$710.55
87480		<1%	34	$675.70
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	58	$669.03
82652		<1%	60	$642.72
87660		<1%	34	$640.69
J3370	Injection, vancomycin hcl, 500 mg	<1%	210	$628.50
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	82	$622.40
87510		<1%	33	$618.27
A9270	Non-covered item or service	<1%	795	$618.17
29125		<1%	29	$612.30
84156		<1%	122	$604.00
C1769	Guide wire	<1%	393	$525.71
J1644	Injection, heparin sodium, per 1000 units	<1%	761	$488.86
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	56	$464.72
88304		<1%	85	$447.37
29515		<1%	14	$437.06
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,297	$431.36
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,543	$426.85
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	324	$410.68
84550		<1%	111	$399.24
J3475	Injection, magnesium sulfate, per 500 mg	<1%	277	$334.28
85018		<1%	40	$299.18
82105		<1%	15	$260.83
87535		<1%	92	$231.28
87400		<1%	162	$211.14
85014		<1%	40	$201.94
76813		<1%	95	$200.85
73590		<1%	64	$191.35
97804		<1%	13	$187.68
88307		<1%	16	$169.52
0011A		<1%	43	$156.80
88141		<1%	125	$149.82
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	26	$147.79
J3480	Injection, potassium chloride, per 2 meq	<1%	29	$146.07
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	587	$132.95
84146		<1%	18	$119.23
0012A		<1%	50	$111.30
82565		<1%	188	$106.43
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,991	$95.24
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	67	$94.72
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	41	$69.39
96415		<1%	102	$65.80
85045		<1%	199	$62.52
73140		<1%	101	$51.12
J8597	Antiemetic drug, oral, not otherwise specified	<1%	1,424	$26.95
82247		<1%	17	$24.28
95886		<1%	60	$15.90
J0780	Injection, prochlorperazine, up to 10 mg	<1%	49	$15.58
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	36	$12.20
81002		<1%	112	$11.14
J2550	Injection, promethazine hcl, up to 50 mg	<1%	52	$6.26
J8540	Dexamethasone, oral, 0.25 mg	<1%	41	$5.48
82977		0%	14	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	33	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	51	$0.00
84520		0%	36	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	51	$0.00
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	0%	15	$0.00
85008		0%	80	$0.00
80329		0%	13	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	50	$0.00
82951		0%	32	$0.00
A0434	Specialty care transport (sct)	0%	68	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCORMICK, R (CFO)